Tag results:
IL-23
Dermal Cell News
Discovery of a Novel RORγ Antagonist with Skin-Restricted Exposure for Topical Treatment of Mild to Moderate Psoriasis
[Scientific Reports] To alleviate the potential safety concerns, identifying compounds with skin-restricted exposure amenable for topical use was of great interest.
Human Immunology News
Chronic Stress Physically Spares but Functionally Impairs Innate-Like Invariant T Cells
[Cell Reports] Investigators report that long-term stress surprisingly abrogates both T helper 1 (TH1)- and TH2-type responses orchestrated by invariant natural killer T cells.
Muscle Cell News
The Cyclophilin Inhibitor NIM-811 Increases Muscle Cell Survival with Hypoxia In Vitro and Improves Gait Performance Following Ischemia–Reperfusion In Vivo
[Scientific Reports] Researchers used an in vitro model of muscle cell ischemia in which primary human skeletal myoblasts were exposed to hypoxic conditions for 6 hours.
Immune Regulation News
Structural Basis for IL-12 and IL-23 Receptor Sharing Reveals a Gateway for Shaping Actions on T versus NK Cells
[Cell] Scientists targeted the shared IL-12Rβ1/p40 interface to design a panel of IL-12 partial agonists that preserved interferon gamma (IFNγ) induction by CD8 + T cells but impaired cytokine production from natural killer (NK) cells in vitro.
Dermal Cell News
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa
[International Journal of Molecular Sciences] The authors discuss the pathogenetic role of various cytokines in Hidradenitis suppurativa and potential therapeutic targets attempted or currently under investigation for this debilitating disease.
Dermal Cell News
Galectin-7 Downregulation in Lesional Keratinocytes Contributes to Enhanced IL-17A Signaling and Skin Pathology in Psoriasis
[Journal of Clinical Investigation] Scientists found that the expression of galectin-7 was reduced in the skin lesions of patients with psoriasis. IL-17A and TNF-α, two cytokines intimately involved in the development of psoriatic lesions, suppressed galectin-7 expression in human primary keratinocytes and the immortalized human keratinocyte cell line HaCaT.